ID    AVR/I/SSAP90
ET    Clinical
PN    D-IK8
PL    8 [Note: any special compound, if present in sequence, is not considered in length]
SR    Not available
SO    Synthetic peptide
TX    Not available
VL    Experimentally validated
XX
TO    VRSA (VRS11a) (clinical isolate)
IC    EC50 = 16 microM
TH    The MTS assay on HaCat cells revealed that D-IK8 have EC50 value of > 256microM, indicating low toxicity to mammalian cells relative to their antimicrobial potency, which suggests a favorable drug safety profile and selective action against bacterial membranes.
XR    PubMed: 27405275
XR    RCSB PDB/PDBsum/PDBe/PDBj/PDBe-KB/MMDB: Not available 
XR    UniProt: Not available
XR    DrugBank: Not available
XX
SQ    SEQUENCE  
      IRIKIRIK 
//

